Kinase modification, particularly phosphorylation, plays a crucial role in regulating almost every aspect of cell biology, including signal transduction, protein-protein interactions, and apoptosis. The dysregulation of kinase modification is a well-established hallmark of numerous pathologies, most notably cancer, inflammatory disorders, and neurodegenerative diseases. Consequently, kinases have become one of the most critical and intensely pursued classes of drug targets. The successful development of kinase inhibitors—from initial hit identification to lead optimization and clinical candidacy—is fundamentally dependent on the precise and reliable measurement of kinase activity. Understanding a compound's potency, selectivity, and mechanism of action requires a sophisticated, multi-faceted analytical approach. At Creative Biolabs, we provide an unparalleled suite of kinase modification measurement services, leveraging over two decades of specialized expertise to empower our clients' drug discovery pipelines with robust, decision-enabling data.
The accurate quantification of kinase modification events is a complex challenge that demands a diverse technological arsenal. A single assay is rarely sufficient to capture the full biological picture. Creative Biolabs offers a comprehensive portfolio of industry-leading biochemical and cell-based assays, ensuring the selection of the optimal method for every unique research objective.
For ultimate precision and universal applicability, radiometric assays remain the undisputed gold standard for direct kinase activity measurement. These assays utilize radiolabeled ATP, as a phosphate donor. The kinase transfers the radioactive phosphate to a specific peptide or protein substrate, and the resulting phosphorylated product is isolated and quantified via scintillation counting or phosphorimaging.
For large-scale screening campaigns, efficiency and scalability are paramount. We offer a range of non-radioactive, homogeneous "mix-and-read" assays designed for high-throughput screening (HTS).
To move beyond purified enzymes and understand kinase activity on a global scale within the native cellular environment, mass spectrometry (MS) is the ultimate discovery tool. Our state-of-the-art LC-MS/MS platforms enable deep phosphoproteome profiling.
Biochemical assays are essential, but true validation requires assessing a compound's effect within a living cell. Creative Biolabs provides critical cell-based services to bridge this gap.
A1: The optimal assay depends entirely on your project's stage and goals. Such as for initial large-scale screening, we recommend luminescence or fluorescence-based HTS assays. Our experts will consult with you to design the most effective strategy.
A2: Many early-stage inhibitors simply compete with ATP for the kinase's binding pocket. These compounds often appear potent in low-ATP biochemical assays but fail in cells where ATP is abundant (~1-10 mM). By testing at high, physiological ATP concentrations, Creative Biolabs ensures the early identification of compounds with true therapeutic potential, saving invaluable time and resources.
A3: Yes. Our mass spectrometry-based phosphoproteomics service is specifically designed for this purpose. We can perform experiments to identify proteins that are directly phosphorylated by your kinase, providing critical insights into its biological role and signaling network.
A4: Every assay at Creative Biolabs is conducted under rigorous quality control standards. We utilize standardized protocols, reference compounds, and robust statistical analysis to ensure the highest level of data integrity, accuracy, and reproducibility.
Accelerate your kinase drug discovery program with a trusted industry leader. Connect with the experts at Creative Biolabs today to discuss your project and discover how our advanced kinase modification measurement services can guide your path to the clinic.